fda tirzepatide shortage update Lilly's weight-loss drug removed from FDA's list Compounded Tirzepatide Crisis! Patients Left

Tirzepatides extended half-life and steady-state exposure allow for consistent therapeutic levels with less frequent dosing compared to daily diabetes medications

This means your monthly cost may rise gradually over the first several months of treatment as your provider adjusts your protocol

Not all individuals will qualify for medication-based treatment

They are not medications, nor are they intended to diagnose, treat, prevent, or cure any disease or medical condition

Primary Handling Editors: Ashley Castellanos-Jankiewicz, Liam Messin and Sonia Muliyil, in collaboration with the Nature Medicine team

staying on the same dose for longer can be helpful if side effects are difficult to manage